News
BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing cancer therapies, today announces that it will have a poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback